The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo

BACKGROUND: Novel synthesized analogs of Aplidin, PM01215 and PM02781, were tested for antiangiogenic effects on primary human endothelial cells in vitro and for inhibition of angiogenesis and tumor growth in vivo. METHODS: Antiangiogenic activity of both derivatives was evaluated by real-time cell...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Borjan, Bojana, Steiner, Normann, Karbon, Silvia, Kern, Johann, Francesch, Andrés, Hermann, Martin, Willenbacher, Wolfgang, Gunsilius, Eberhard, Untergasser, Gerold
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615365/
https://ncbi.nlm.nih.gov/pubmed/26483043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1729-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki